Pinnacle Associates’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$589K Buy
1,912
+811
+74% +$252K 0.01% 642
2026
Q2
$308K Sell
1,101
-46
-4% -$12.1K ﹤0.01% 804
2026
Q1
$306K Buy
1,147
+21
+2% +$5.69K ﹤0.01% 795
2025
Q4
$282K Buy
1,126
+42
+4% +$11.2K ﹤0.01% 807
2025
Q3
$311K Buy
1,084
+8
+0.7% +$2.14K ﹤0.01% 741
2025
Q2
$282K Sell
1,076
-121
-10% -$29.5K ﹤0.01% 750
2025
Q1
$279K Buy
1,197
+137
+13% +$33.2K ﹤0.01% 729
2024
Q4
$243K Buy
+1,060
New +$243K ﹤0.01% 768
2024
Q3
– Sell
-999
Closed -$203K – 828
2024
Q2
$203K Sell
999
-39
-4% -$7.93K ﹤0.01% 775
2024
Q1
$227K Buy
1,038
+17
+2% +$3.74K ﹤0.01% 768
2023
Q4
$232K Buy
+1,021
New +$214K ﹤0.01% 753
2023
Q3
– Sell
-1,076
Closed -$223K – 823
2023
Q2
$223K Buy
+1,076
New +$209K ﹤0.01% 750

Other funds holding LH

Pinnacle Associates's LH Position: Q3 2026 in Review

Pinnacle Associates increased its Labcorp (LH) stake by 74% in Q3 2026, buying an estimated $252K and bringing the position to 1,912 shares worth $589K. The position accounts for 0.01% of the portfolio, ranked #642.

Pinnacle Associates first reported a position in LH in Q2 2023 and has held it in 12 quarters since. 549 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Pinnacle Associates held 1,912 shares of Labcorp worth $589K as of Q3 2026.
  • Pinnacle Associates bought 811 Labcorp shares in Q3 2026, an estimated $252K.
  • Labcorp made up 0.01% of Pinnacle Associates's portfolio in Q3 2026, its #642 holding.
  • Pinnacle Associates first reported a position in Labcorp in Q2 2023 and has held it in 12 quarters since.
  • 549 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.